| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Contents page
|
|
|
|
28 |
3 |
p.
|
artikel
|
| 2 |
Cordycepin and kinase inhibition in cancer
|
Khan, Md Asaduzzaman
|
|
|
28 |
3 |
p.
|
artikel
|
| 3 |
Corrigendum to “Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors” [Drug Discov. Today 28(1) (2023) 103394]
|
Lv, Yixin
|
|
|
28 |
3 |
p.
|
artikel
|
| 4 |
Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids
|
Mendonça, Monique C.P.
|
|
|
28 |
3 |
p.
|
artikel
|
| 5 |
Gene and cell therapy approaches for familial hypercholesterolemia: An update
|
Parsamanesh, Negin
|
|
|
28 |
3 |
p.
|
artikel
|
| 6 |
Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
|
Moore, Kendall B.E.
|
|
|
28 |
3 |
p.
|
artikel
|
| 7 |
Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus
|
Kinch, Michael S.
|
|
|
28 |
3 |
p.
|
artikel
|
| 8 |
Intra-articular nanodrug delivery strategies for treating osteoarthritis
|
Zhou, Dongyang
|
|
|
28 |
3 |
p.
|
artikel
|
| 9 |
Medicinal chemistry insights into antiviral peptidomimetics
|
Ding, Dang
|
|
|
28 |
3 |
p.
|
artikel
|
| 10 |
Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer
|
Ganji, Chaithanya
|
|
|
28 |
3 |
p.
|
artikel
|
| 11 |
Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis
|
Li, Haiyan
|
|
|
28 |
3 |
p.
|
artikel
|
| 12 |
New trends for osteoarthritis: Biomaterials, models and modeling
|
Manivong, Seng
|
|
|
28 |
3 |
p.
|
artikel
|
| 13 |
Profiling disease-selective drug targets: From proteomics to ligandomics
|
Waduge, Prabuddha
|
|
|
28 |
3 |
p.
|
artikel
|
| 14 |
Rapid progress in neuroimaging technologies fuels central nervous system translational medicine
|
Kong, Linghui
|
|
|
28 |
3 |
p.
|
artikel
|
| 15 |
Recent trends in interorganizational deal networks in pharmaceutical and biotechnology industries
|
Yashiro, Kentaro
|
|
|
28 |
3 |
p.
|
artikel
|
| 16 |
Role of transcription termination factor Rho in anti-tuberculosis drug discovery
|
Kumar, Sunil
|
|
|
28 |
3 |
p.
|
artikel
|
| 17 |
Targeting caseinolytic protease P and its AAA1 chaperone for tuberculosis treatment
|
Xu, Xin
|
|
|
28 |
3 |
p.
|
artikel
|
| 18 |
The myotonic dystrophy type 1 drug development pipeline: 2022 edition
|
Pascual-Gilabert, Marta
|
|
|
28 |
3 |
p.
|
artikel
|
| 19 |
Transforming patient engagement in clinical trials: Moving from a transactional relationship to human-centered care
|
Staley, Alicia
|
|
|
28 |
3 |
p.
|
artikel
|
| 20 |
Translating precision medicine for autism spectrum disorder: A pressing need
|
Pérez-Cano, Laura
|
|
|
28 |
3 |
p.
|
artikel
|
Tijdschrift beschrijving